Pfizer and BioNTech want to get approval from the FDA for their coronavirus vaccine. They plan to do this in November. The vaccine will be used by children between 6 months and 5 years old.
Pfizer had previously said it planned to apply for U.S. approval for the jab for children aged 5-11 in early October, but after speaking at the Morgan Stanley Global Healthcare Conference, D’Amelio said they will also be applying to give it to children aged 6 months-5 years “in the weeks shortly thereafter” if all of the data is positive.
In August, the FDA approved the BioNTech/Pfizer vaccine. It is the first COVID-19 vaccine to be fully licensed for use in the United States.
In Europe, The Moderna vaccines have been authorized by the European Medicines Agency for children over 12.